Literature DB >> 2417747

Potential deleterious effects of inotropic agents in the therapy of chronic heart failure.

A M Katz.   

Abstract

Inotropic stimulation of the failing heart, although a logical adjunct in short-term efforts to maintain circulatory function in patients with heart failure, has several potentially deleterious effects that may limit its usefulness in long-term therapy for patients with congestive heart failure. These deleterious effects include cell damage caused by an increased rate of energy expenditure, exacerbation of relaxation abnormalities, and potential arrhythmogenic side effects that may result from increased cytosolic Ca++ and cyclic AMP concentrations in the inotropically stimulated myocardium. Recognition of these possible side effects should allow the therapeutic benefits of this approach to long-term therapy to be evaluated in carefully controlled clinical trials.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2417747

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  33 in total

Review 1.  What do we know and we do not know about cardiovascular autonomic neuropathy in diabetes.

Authors:  Rodica Pop-Busui
Journal:  J Cardiovasc Transl Res       Date:  2012-05-30       Impact factor: 4.132

Review 2.  When, and when not, to use digoxin in the elderly.

Authors:  A T Gosselink; D J van Veldhuisen; H J Crijns
Journal:  Drugs Aging       Date:  1997-06       Impact factor: 3.923

Review 3.  What do the newer inotropic drugs have to offer?

Authors:  S Sasayama
Journal:  Cardiovasc Drugs Ther       Date:  1992-02       Impact factor: 3.727

4.  S100A1 DNA-based Inotropic Therapy Protects Against Proarrhythmogenic Ryanodine Receptor 2 Dysfunction.

Authors:  Julia Ritterhoff; Mirko Völkers; Andreas Seitz; Kristin Spaich; Erhe Gao; Karsten Peppel; Sven T Pleger; Wolfram H Zimmermann; Oliver Friedrich; Rainer H A Fink; Walter J Koch; Hugo A Katus; Patrick Most
Journal:  Mol Ther       Date:  2015-05-25       Impact factor: 11.454

Review 5.  Energy requirements of contraction and relaxation: implications for inotropic stimulation of the failing heart.

Authors:  A M Katz
Journal:  Basic Res Cardiol       Date:  1989       Impact factor: 17.165

Review 6.  Selective updates on mechanisms of action of positive inotropic agents.

Authors:  G Grupp
Journal:  Mol Cell Biochem       Date:  1987-08       Impact factor: 3.396

Review 7.  Cardiovascular autonomic neuropathies as complications of diabetes mellitus.

Authors:  Michael Kuehl; Martin J Stevens
Journal:  Nat Rev Endocrinol       Date:  2012-02-28       Impact factor: 43.330

8.  Digoxin revived?

Authors:  L H Opie
Journal:  Cardiovasc Drugs Ther       Date:  1989-03       Impact factor: 3.727

Review 9.  Cardiomyocyte Ca2+ homeostasis as a therapeutic target in heart failure with reduced and preserved ejection fraction.

Authors:  Deborah Peana; Timothy L Domeier
Journal:  Curr Opin Pharmacol       Date:  2017-04-22       Impact factor: 5.547

Review 10.  Pimobendan. A review of its pharmacology and therapeutic potential in congestive heart failure.

Authors:  A Fitton; R N Brogden
Journal:  Drugs Aging       Date:  1994-05       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.